enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Raloxifene - Wikipedia

   en.wikipedia.org/wiki/Raloxifene

   Raloxifene, sold under the brand name Evista among others, is a medication used to prevent and treat osteoporosis in postmenopausal women and those on glucocorticoids. [6] For osteoporosis it is less preferred than bisphosphonates. [6]

3. 8 Tried-and-True Tips for Getting Back into Working Out This Year

   www.aol.com/8-tried-true-tips-getting-115700007.html

   Weight loss is one of the main motivators for exercise but it shouldn’t be the only one since focusing too much on weight loss, and getting frustrated if you aren’t losing the desired amount ...

4. Are laxatives for weight loss safe? - AOL

   www.aol.com/laxatives-weight-loss-safe-153000701...

   Regular physical activity can help with weight loss and weight maintenance. For the best results, aim to exercise at a moderate level for at least 30 minutes per day, three times per week, and ...

5. The 5 Best Drinks if You're Taking Weight Loss ... - AOL

   www.aol.com/lifestyle/5-best-drinks-youre-taking...

   Certain beverages can complement the effects of weight loss medications, support hydration and provide essential nutrients, while others may lead to unwanted side effects or make it harder to lose ...

6. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   Weight loss drugs have been developed since the early twentieth century, and many have been banned or withdrawn from the market due to adverse effects, including deaths; other drugs proved ineffective. Although many earlier drugs were stimulants such as amphetamines, in the early 2020s, GLP-1 receptor agonists became popular for weight loss.

7. Selective estrogen receptor modulator - Wikipedia

   en.wikipedia.org/wiki/Selective_estrogen...

   When the interactive distance between raloxifene and Asp-351 is increased from 2.7 Å to 3.5-5 Å it causes increased estrogen-like action of the raloxifene-ERα complex. When the piperidine ring of raloxifene is replaced by cyclohexane, the ligand loses antiestrogenic properties and becomes a full agonist. The interaction between SERM's ...